Percentage of patients, regardless of age, with a current diagnosis of psoriasis or hidradenitis suppurativa who were seen for an office visit during the one-year measurement period and who have a documented discussion regarding increased risk for cardiovascular comorbidities including a referral to their PCP for that screening